Mynvax
Developer of novel drugs designed to be used in vaccines for respiratory viruses. The company's drugs specialize in the treatment of flu and infectious disease for the healthcare industry, enabling me...
Valuation
$29.8M
Market implied
Share Price
N/A
Total Raised
$12.7M
Last Round
N/A